ArticleFrontiers in endocrinology2026
Life activities of elderly patients with operated nonfunctional pituitary adenoma.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: To evaluate the clinical findings of nonfunctional pituitary adenomas in the geriatric population, functional status, cognitive function, quality of life, frailty, and incidence of anxiety and depression during treatment and follow-up. Material-method: We evaluated operated nonfunctional pituitary adenoma (NFA) cases aged 65 years and older followed up in our clinic between 2010 and 2022. Patients without pituitary adenoma who were followed up in the geriatrics outpatient clinic were included as the control group in the study. Data on clinical, endocrinological, pathological, and radiological findings, as well as on treatment methods, were taken from the files. Bioimpedance was used to assess muscle strength, walking speed, and muscle to fat ratio in patients. In addition, quality of life, anxiety, depression, cognitive function, and vulnerability were assessed. Results: The study included 43 elderly patients diagnosed with NFA and 60 elderly patients without NFA. The mean ages, sex ratios, and body mass indices (BMI) of patients diagnosed with NFA and the control group were similar (age: 70.9 ± 0.66; 73.1 ± 0.8, p = 0.6; female/male: 24/19, 35/25, p = 0.1; BMI: 28.3 ± 3.9/28.5 ± 4.8, p = 0.9, respectively). Cognition status (MMT: 28;29, p=0.002), frailty scores (2[2-3]; 1[1-2], M[IQR], p<0.001), sarcopenia rates (62%; 30%, p=0.007) was worse in patients with NFA. Conclusion: In the study comparing patients diagnosed with surgical pituitary NFA with patients of similar age and comorbidity, the frailty score and rate of sarcopenia were higher and their cognition was worse. The findings indicate that complications from surgery and postoperative treatment in patients with pituitary NFA make elderly patients more vulnerable. We emphasize that patients with NFA in this age group should be examined more carefully.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.